3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
57
Endometrial Neoplasms
7
Neoplasm Metastasis
6
Ovarian Neoplasms
5
Polycystic Ovary Syndrome
4
Neoplasms
4
Advanced Breast Cancer
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Prostatic Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Neoplasms by Site
2
Infertility
2
HR+/HER2- Breast Cancer
2
Estrogen Receptor-positive Breast Cancer
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sexual Dysfunctions, Psychological
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Low-Grade Serous Ovarian Cancer
1
Low Grade Serous Ovarian Carcinoma
1
Low Grade Serous Ovarian Cancer
1
Locoregional Recurrence
1
Leiomyoma
1
Interventions
Practice Guidelines as Topic
5
Standard of Care
4
Specimen Handling
3
Docetaxel
3
pertuzumab
2
Trastuzumab
2
Taxes
2
Paclitaxel
2
Minoxidil
2
Methods
2
Interviews as Topic
2
High-Energy Shock Waves
2
Educational Status
2
Early Intervention, Educational
2
Biopsy
2
trastuzumab biosimilar HLX02
1
Yoga
1
Transcutaneous Electric Nerve Stimulation
1
Radiation Dose Hypofractionation
1
Palliative Care
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Nutrition Assessment
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Goserelin
1
Geriatric Assessment
1
Genetic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
Letrozole
×
90 days
×
Clear all
No trials found.